The product is a game changer. No Doubt !
The biggest problem is the wages are extreme, this has stopped me from buying more than I would normally buy. I would rather wages are lower with performance based incentives.
To me this is the product AHZ can sell in volume and have the data like no other competitor. AHZ needs a deal with this product and with continuous discloser on the trial this may happen sooner than investors think.
Ann: Promising Interim Results from TAVR Animal Study, page-24
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.15 |
Change
0.000(0.00%) |
Mkt cap ! $291.2M | |||
| Open | High | Low | Value | Volume |
| $15.00 | $15.15 | $14.60 | $347.8K | 23.20K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 760 | $15.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.15 | 388 | 1 |
View Market Depth
| Last trade - 15.58pm 30/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |